Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science
Year: 2017
Type: editorial
Abstract: “Regenerative medicine” or “tissue regeneration” had become to an inspired term recently since it has been realized in the last decade that many organs such as the skin display morphological plasticity and possess healing capacity instead of being a post-mitotic terminally developed organ (1,2).
Source: Annals of Translational Medicine
Institution: Medical University of Vienna
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2607228420
